0001193125-12-342773.txt : 20120808 0001193125-12-342773.hdr.sgml : 20120808 20120808095157 ACCESSION NUMBER: 0001193125-12-342773 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 4 CONFORMED PERIOD OF REPORT: 20120808 FILED AS OF DATE: 20120808 DATE AS OF CHANGE: 20120808 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Theratechnologies Inc. CENTRAL INDEX KEY: 0001512717 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A8 FISCAL YEAR END: 1130 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-35203 FILM NUMBER: 121015348 BUSINESS ADDRESS: STREET 1: 2310 ALFRED-NOBEL BLVD. CITY: MONTREAL STATE: A8 ZIP: H4S 2B4 BUSINESS PHONE: 514-336-7800 MAIL ADDRESS: STREET 1: 2310 ALFRED-NOBEL BLVD. CITY: MONTREAL STATE: A8 ZIP: H4S 2B4 6-K 1 d393105d6k.htm FORM 6-K Form 6-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 6-K

 

 

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16

under the Securities Exchange Act of 1934

August 8, 2012

Commission File Number 001-35203

 

 

THERATECHNOLOGIES INC.

(Translation of registrant’s name into English)

 

 

2310 Alfred-Nobel Boulevard

Montréal, Québec, Canada

H4S 2B4

(Address of principal executive offices)

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F ¨            Form 40-F x

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):

Yes ¨            No x

Note: Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):

Yes ¨            No x

Note: Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant’s “home country”), or under the rules of the home country exchange on which the registrant’s securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant’s security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.

Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes ¨            No x

If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-                    .

 

 

 


THERATECHNOLOGIES INC.

 

Exhibit

  

Description

99.1    Press release dated August 7, 2012

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

THERATECHNOLOGIES INC.
By:   /s/ Jocelyn Lafond

Name:

Title:

 

Jocelyn Lafond

Vice President, Legal Affairs

Date: August 8, 2012

EX-99.1 2 d393105dex991.htm EXHIBIT 99.1 Exhibit 99.1

LOGO

 

EXHIBIT 99.1

 

LOGO

Theratechnologies Receives Notification from NASDAQ Relating to Minimum Bid Price

Montréal, Canada – August 7, 2012 – Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THER) today announced that it received a letter from the listing qualifications department staff of The NASDAQ Stock Market LLC (NASDAQ) on August 7, 2012 notifying Theratechnologies that, for the last 30 consecutive business days, the bid price of its common shares had closed below $1.00 per share, the minimum closing bid price required by the continued listing requirements set forth in NASDAQ Listing Rule 5450(a)(1).

Pursuant to NASDAQ Listing Rule 5810(c)(3)(A), Theratechnologies has 180 calendar days, or until February 4, 2013, to regain compliance with the minimum bid price requirement. If at any time before this date Theratechnologies’ common shares have a closing bid price of $1.00 or more for a minimum of 10 consecutive business days, NASDAQ staff will notify Theratechnologies that it has regained compliance. As a result, the notice has no effect at this time on the listing of Theratechnologies’ common shares on The NASDAQ Global Market, which will continue to trade under the symbol “THER”.

If Theratechnologies does not regain compliance with NASDAQ Listing Rule 5450(a)(1) by February 4, 2013, Theratechnologies may be eligible for more time if it submits an application to transfer its securities to The NASDAQ Capital Market. Following submission of the application, Theratechnologies may be eligible for an additional 180-day period to regain compliance with the minimum bid price requirement if it meets the continued listing requirement for market value of publicly held shares and all other initial listing standards, with the exception of the bid price requirement, for The NASDAQ Capital Market and provides notice of its intention to cure the deficiency during the second compliance period. Should NASDAQ conclude that Theratechnologies will not be able to cure the deficiency, NASDAQ will provide notice that its securities will be subject to delisting. Alternatively, Theratechnologies may appeal NASDAQ’s decision to a Listing Qualifications Panel.

Theratechnologies intends to monitor the bid price for its common shares between now and February 4, 2013, and will assess all its available options under the circumstances during this period.

About Theratechnologies

Theratechnologies (TSX: TH) (NASDAQ: THER) is a specialty pharmaceutical company that discovers and develops innovative therapeutic peptide products, with an emphasis on growth-hormone releasing factor peptides. For more information about Theratechnologies, please visit www.theratech.com. Additional information, including the public documents filed by Theratechnologies, is also available on SEDAR at www.sedar.com and on the Securities and Exchange Commission’s website at www.sec.gov.

 


We refer potential investor to the “Risk Factors” section of our Annual Information Form (AIF) dated February 27, 2012. The AIF is available at www.sedar.com and at www.sec.gov under our public filings.

-30-

Contact:

Luc Tanguay Senior Executive Vice President & Chief Financial Officer

Theratechnologies Inc.

Phone: 514 336-4804 (x204)

GRAPHIC 3 g393105g21v86.jpg GRAPHIC begin 644 g393105g21v86.jpg M_]C_X0`817AI9@``24DJ``@``````````````/_L`!%$=6-K>0`!``0```!D M``#_X004:'1T<#HO+VYS+F%D;V)E+F-O;2]X87`O,2XP+P`\/WAP86-K970@ M8F5G:6X](N^[OR(@:60](EG)E4WI.5&-Z:V,Y9"(_/B`\ M>#IX;7!M971A('AM;&YS.G@](F%D;V)E.FYS.FUE=&$O(B!X.GAM<'1K/2)! M9&]B92!835`@0V]R92`U+C`M8S`V,"`V,2XQ,S0W-S7!E+U)E&UL M;G,Z>&UP/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C`O(B!X;6QN&UP34TZ1&5R:79E9$9R;VT@&UP;65T83X@/#]X<&%C M:V5T(&5N9#TB"\T8C0'6'?K_^X` M#D%D;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$! M`0$!`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$" M`0$"`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,# M`P,#`P,#`P,#`P,#_\``$0@!:P`R`P$1``(1`0,1`?_$`)X```("`@,``P`` M```````````*"`D'"P0%!@$"`P$!`````````````````````!````8!`@(# M!A$%"0T)`0```0(#!`4&!P@)`!$2$PHA%!4U-AGUW&"HD-SHU34I3H1`0`````` M``````````````#_V@`,`P$``A$#$0`_`'^.`.`3SUL[OFXMKEUIY+VS]C"I MUM2S)1^5PI_W=-F'<,TCZ(,I:]M5.[;E[4)D^D3..H]WCF&<90"KKJW^\0-+ M=ECKM/9,8JM&L3X57<.%U3'57765.)CG,(F,81$1$1X"%N\[J,U2:1=N;4'J M9TA!05,LX7BX&XO&^0ZR_M<4?'Z=ACHR^/8R,93$.D2=K\%)'E$5'1EVH),5 M2'1.)RB4*D/Q+N/O@]#?@*5-RL."71YFZSP@T3Z/+N\^`79[(MC"H5?:3 MA,KQK9%QD'/V=,S7')]E6Y+S4S+5>W/*#!-9)^?I.5D&$-72N$DSF$"+/EU` M#I+'$0RSVK+[DG4W_''3[_3G0N`NTTJHJ-]+^F]!8HD61P)A]%4@\A$BB>/: MZ0Y1$!$!$IBB'2`J*XBMB3(AORB= M1^=(I`#NB<0`.`TSWA.Y?XR4^C9X,]2KY&_XOT?%?Y_4\!O9>`XKYDTDV3R- MD&R+QA(-7#)ZT<$!1NZ:.TCH.6RZ9@$JB*Z*ABF*/<$HB'`)*:*]5+?LWFLK M-NVMK=1GZSH%SQE2P9LT/ZG`AY*3IM0C[0UPH-FAK?691L MIG*@&(LQG(!X_C7)!`X>H4'D(\A[O`7U8!EXFO:7\'S4_*1T'#Q>"\7NY.6F M'K:,C8YJA0X(RSE^^>JH-6;=$H`47WT]U=AN*N8#92VII9KJ- MS#J0N<-6,\91H#LLEB^H4:OS#2;E:JPO3$'$7)QQ'46F^M4VU.K$Q<(S6;=< MX7YO4_GX!F#@#@(Z:H=).F_6E MBJ5PIJCQ!3\RXVEE"N30-K8J'<1,FFF=)"99=D!L5]/%PVI_=QU3YJQY%)L6:%* M:5A_'"E%QZ2+=LQC'^0Z_NJZOLKZ3-B*NTNG82P;(+ M0]]U>W*)KKYI-K(O747[XPL5[BK'5*G3IZ2CW)8!BQAI*R2S5N=\7JT>M0;A MP;9KN[0[LF2E&RIN@-,6ZYM$$_:H2K9(R9BAE7/?ABSPZ\1:(.FTW7*5BN0C M950YQ[T)/P[R&DUP*Q(^9N7"1P!J'[2#19\O-.^B!\_'VRI]%CY4?6_:'N;V MW['P$X>`QEFNGR60\-9;H$,N1M,7G&5]I\4Y4/U:;>2LU5E85BNHIS+U9$G3 MTAA'F'(`Y\`M3V1_*U(5VW[-I5<.6L#J`TL:@\Q5G-F-Y`Q&EMA75DMCJ9AY MY_%*=!V,:NM_P`5T^Q!\YS5]$R6 M#L-U*%>&&WMH"U)EA\EY";,&0*2:+&OU5\LP9N$P*8TY),B)B(]/HA)S8FV] MFVV_MQX2PY.5]K#9INT:7,&H1R5!,LFOE2^-FS]S7Y-P"*2JQL>5XC"OD*(B MF`QIU"]U4PF#/V[36:/;ML#<"A,CI,U*B.D#/\L],^ZOJ6DC7,:V&Q5N23%7 MTI'L59HIFY;'#D8CA(ABB!@`0#3B^>[-OZ=L/T2_,C[:<_$E^@O5>3WL7K7Y MN`WHG`'`+5[B79SJ5J=U&3.MC1;JHRKMYZN;5UR]_N^)!F`JF1)-P")7L_*1 MM4ME!LU=L\V"!!DW3*3.TDE"=^(E%P[9QD>ZY+=Z*JD M142!IO@*K]YS2'J;UW[?F8-*^E3)&/\`&5]RHM7HZR2F1@GF\+8L>Q1S-LL\%B\2-'BY;G3*"_6IA5U^&#TX_"1O]U7\Q+Q87X^? MK-^H\8^X_P#Q<`TKP!P$$-;.YIH:V[X%A-:NM0E-Q8]FFBSZMTHWA*T9)M+5 M`YT3NZ_CNI,9NWOXX')!2,][T*Q35]*=8H\!1Y+]L;VB8U\LT91FK2PMTC&* M24B,+UA%BX`!Y`=%.?RC!R12G#NAUC<@\O1`![G`=9^,JVE/@CK'_F=Q]_UH MX#A/^V6;5I4!\!8SUH6*0$>BC&M,2XX;++*#R!-,JB^9Q(!E##R#T>[P$Q_Q M#VGWZL^J+[O_`.T.\GJ3\6/P`\L?C/\`6O-NC*!2;C>YKI^! MJ35K!;I;J^76>#*W$NYE_P!7SYAT^]61^7Y^`2#V+]N+'6\-<,][S^YC`(ZA MK%E[.-PKV"<-7=RZE,8U.JTI9JR*YEZT8R6N04,[!6+:M8I9=P@X M77240"27:G-,FG["^AC2A=,68&PSB^OT;7Q@TMI\WN+*-34_>@^JN24G,:Y" MNP4<52'6=-D04;'`4%#`3I%$2AP#1)-)FDQVB19/3-IW<(.4BJ$4##&-E$UT M5B`8I@'WM"!TU4S?]@@/`+;[NFV'$:`49+>5VIJS7-.N?],+56YZ@<(4N#:Q MF#=1>!P?-E$RC2T\D8RR+CM9<&J-]HENI:KD> MER;IVFOR$&HN/0`3\D2OA-W`$>YW.`6I[)I>TXO;[RMH_M)`A\SZ*=5>9L79 M/J3@`2DHD]@L3FQQTBNW,/7%:O+!X:8IF,4`,K%J@'/H\!8MOOZ.YK7'M8:J M\*4Z)<3F2(ZH,\L8OBF1.MD)6\XCE6=Z8P,:CR$5I*UQ<0\B$"`("95^`<_R M"'3;&.Y!CG<7T%8=LS"T1JV=\2TJKXKU&T%=X@G;*UD.GQ#>`7LK^&.L9^G7 MJWZ??#5PFF&3-Z'4_A[2IMFZP[IF&>AX]K=,"Y3Q'1ZW( M.VR4*/.TNJU""CE%".95P[D)@JSL$2G%K'(.'*G121.8H:D#YFNJ#X M"6SZ"WSO_:K[Z-/PR]#R;_=>M**N%^L654.8)1<`J MUKU[,30\R9_L>KS;VU2Y%VZ]0USD)";O2>-@L!,=VJ>EG7?TS-Q"5+ME'M>/ M)&POS"XD4V3MY%.5OWPK!)0RIU`C5@[LH-YR3F>K9>W7MPS*VN.(I#U)U#XI M&3R$M&SB:*I'`Q5BR'D*Z6"R1]5?*HD!Y&PS&-7<%`0!\GS'F#=/F0PU\E6/ M/BM\R'D?`_$U\E7M#XO/U/[0]BX#*/`'`+*[I/:"I33=J(1V_=NO3O)ZX->; MDR32Q5F':S/8N$W$FT1=Q;"%0.!GK]-4BK<@ M4CZ]=1O:U=-^F.WZV=0F8L,Z8<45-_4$)3&N-XC`4O;XA2]6:+K$(W;QH5#* M"[DK>5F$"N".[$LLDF)A$#B40X!\'3S9YR[8`P;<[.^&3LMMP]C.SV&2,BW; M#(3D]2X25EGPMVB2#5N+M^[44Z"1")DZ7(I0``#@(G;J>N&V[WD/B]^3CU'EQ[#Z/[G@+K.`QAFZ^+XLPOEW)S5L M5XYQSC"_7QNT,'2*Z7J%4EK`BV,7\I5U(\"B'Y^`6*[))IYK">A_(VOJW)(V MS4MK5SGEN=R#DV612=64U:JMWD(8M:0D52'=MV4K>64M-O@*H`/'+M$50-WL MAT`DKVK+[DG4W_''3[_3G0N`NQTH`)=+6FL#`)3!@'#@"4P"4P"&.ZX`@(#R M$!`?R#P$<]VJNPUKVO-PN$GR)&C%]&FHQVH*W5@1)U$8JM$Q&N"F4Y%(LVDV M"*B9O1*H4!#N@'`:=+SVY"_3DA]#[S)>V%?B]_0?H>+_`&/U'`;S?@.BM%;B M+C6;%4)]L#V!M4%+UN;9B/('<1.1[B,DFPB(&Y`NS='+SY#Z/`*`[#&J"O[8 MN:]0.Q%K0L3#%^1,;9PMEVT=7JW+EA:?G'%V3'*+)8)I0GAB, M0.8AGZ\D\CRCWZQ%!0)V=JR^Y)U-_P`<=/O].="X"\/33]'+`'_!/%7^XL#P M"WO:;=S"IXYTV3FV1I\?^=+7!K;&O8@0Q91^4]8J5C>]3#./FUK&V8*F".L& M2VAO`,-&+B5RY1D5GG1!!`IE0@A^$\FOT_6?ND?,[[9;?>%?IKVY\7?NWU7` M/.\`B"ZL1*-W;$5>:J147`@N`*]:K.SL[Y[W`=ITB8FW/JOJGTA3SN!.CB MK45,VZKV9FPJ4\SLE48L'DW6LO&A4(.4C6YR)1MA8-5!2Y"@5,>KX#*$?MS] MK3S%7X#$N0]Q;"&GC%,+78JH%=8RL4?7;&SKD-&-H9FC&R&(,(PEM>/$XUJ4 MG24G&9E3AS.J`F$W`6U[4O9X=,&V](F98BZR;F;DI"3F5DE5")KMD5ED3@P?P"SLIVM;9OAY.1B M7N1LWE>1;]Y'.RIX(MJA"N6+A1JN!%"J0_E#@.#^+GV9OE'SE_,+; MOX3@#\7/LS?*/G+^86W?PG`'XN?9F^4?.7\PMN_A.`/Q<^S-\H^EF.HJJH83&,(B)C" M(CW>`_+[,_;E^H-HQ_JPX5_8K@#[,_;E^H-HQ_JPX5_8K@#[,_;E^H-HQ_JP MX5_8K@#[,_;E^H-HQ_JPX5_8K@#[,_;E^H-HQ_JPX5_8K@,C?,OT??55TX_% MEYE?B3QM\3OR4^37Q;_J3Q;[#P$EN`.`4\W%=]+5?<]6]DVR=E#`S'4;JDII MG<;FG-TXS:2N-\-RK%PBSG(J+3EI*%IG?E1>."-I6FT?.>D"8 M4W[DNG;M*.D'1Q?]=.J;=FDHQ"H2U';R^(L`9.O54DT%[]=(:I,VZ)Z!0\9T M-J:*>3::BJ;85T.J3,5-0X]'I`_/IJFI>RZ*IJ;F)%<[F M0E9>5HL"^DI)^Y4$5'#Q\]7.JJ;5V;DJSD-U/(P#:G2-ACH"Q646=<=QDG,*U=.53?*-"O60'9HKGZX#$* M0X5[?B*=/?Z&;?=%_:6^W%_++Y`/0\?_`+OU7`,<NE:M3IFE),Z6EW3:DJ0R:B>`\.IJ)G`2G(?TC)?1=]X/JG?D-^CO5>+?S>L_FX#>KI.XJA%8SLU"R.Y3%M5[+9G0$BZZWD%&*9@? M+K%8L;&G*,G:J0BV,H%C/:HW[&5V.]1\G%O6DE&R%GT[/F$@P<(O&+YDZS?0 M%FSMF[;G40`O.TU?1RP!_P`$\5?[BP/`*M=HXW3H M#*5-)LT:#7R&?]8>KFT5[%.26.-9!M8(_%U1=S;1W+TF:F(L[I@A=K:+`&TF MT.<"05=!^ZD3-N:'3#O/PK&+?AU"?=2?,\]H+?2X^L)[2\F_`.`A M-KGV\-(VXYBGS1:L\2Q&0H5BHZ>5*S('4A,A8\EW:1$E9J@W:.ZN:KKM8$D^ M^$2G.Q?%2(1VW<)E`G`*BY][(OJ)+C^Q80TI;J^6&6F>Q.F;I?39GY"Y2%"3 M/$2Z,W"&?!0[8C3)9S%R39-=)SG9V*E99,T8U.%)4Y"TXPK*K8L<@5$A'`KI%``$2&[H"%] M&USL9:'=J=DYL&&ZS*Y&SQ-1RD99=1.51C9G(JS!T4O?\)44F3%G"X^K3U0! MZYM&HD6/`Q9)TRKV1'G9PC$#@=PV20`ZY`:PO>9,2XPQC+YKR+DNBTG$$#7DK9,9.LUI MA8>B,*TY11<-)Q:TO7B4,,:_2.W#CZSNZ# MINH6H369="NEV$8?%E(+5:5,OD3"F",=-W==C<'Z*BI>15F=<=I*%Y&3,J`A3O/ M48VYGOO[:VU7;WTDIINQKCJ:U59VKT>Z59M[$HJ:Z2+R*DE&XBJ4[ZJXT9PC M9P`D69I6AT9$Q3*OH>T\: MP]V/4+C;9`U69,L\-H\VBI_,K?.,C4I!>/L656=,RF^I>-ZO(.78KH=_,T#A M"5I4Y'`0U:(\62*9P4G,-A)I@T2:2M%].8432YI\Q?A>"8M$V:B].J[!O99D MJ90)WU:;HZ([N%NDE0#]\=2CYVY4_OCCP$I>`.`4J3%.([8>X\*B!36G;8*% M:!4.?6*-TD!7!MTQ]*()5R0$>A^0IO[IN`;5X`X!3G8Z9-`WINT6O0;I`[)J M(QNV*X`@`H5!Q:LW.%T@,']XJND4YO[I@Y\`V-P!P!P"P^[WLI:T-9>O'"^O M#0GJZJ.DG*>-L"'PQ*VAZZOD7=/V4X`^Q7[2K_;K'_EWG3]E.`P7C3LWN^GA MK(N7LN8KW>*10LF9^F&5@S3=ZS/YJC;#DR;CEI-PPE+;((U(%95XT7F71DSG M[I1<'Y>J'@,Z?8K]I5_MUC_R[SI^RG`'V*_:5?[=8_\`+O.G[*Q<`Q[P!P!P!P!P!P!P!P!P!P!P!P!P!P M!P!P$#=%^Y+I2U^6+435]--NL%MD=,&3GF*\G.I"G3T+`&FT'\W',):IV=RU M/7;37YU:N/3M%&SH7(H(@JJ@DFJB90)Y<`N+N8]I7TC[?N:G&EJA8WR+K"U/ MQCIM'V;&F'W3!C!4R;=H@NC4['ET'1FZP=5P&$ M])?:J]-F5,V573]K,TR9QV]KY?GS"-I4YF3K)/'+U[*N091B=EL$G6:!8:>V MDGJA$4GSB'5B4SFYN7;<@"?@&I.F3_#)ZCI^J#U'^'Z/J/S^AP'VX#$N?'MB MC<%9ID:?WQ[[6&)3WR8D5DU[7'2T77(M"8<>F<&71I,1%*ID4'N)N M.F`?O@B(6V;M>N**V[MOW47J?5D8YG$$FE(80"F_LNNV="8.TILMPC.]?"V:R=:Z\UE57(- MR0&4MU2Q/;I)S(UQI&/9%$SF.ELHE64LLP\2,5>02DFJ*IA*V`!"QS?GT58B MUG;8^JJ/R#4X&1N^%L,9)SIAJ[NV2(6&AWS%M3DKLBI"3($[\81]I90*D5)H M`84'3)T8#E$Y$CIAKD_MWM9WRG6C[K3YA?C1QZCY4/0^,;]<>WO9>`V__`?! MB@8!*8`,4P"4Q3``@8!#D("`]P0$.`3`ONA_>%V2]2F=\L;/^-Z1JYT-:D;N M]R=9M(]L6(I-XAO$L!S2`UB&)::5/J,VG2!K&OX-X\46C$F[64CU3,FSLX8? M2T(;S>_MJ/PS9MV?%D+HIT$8%LR5Q#3]7#*0<]DN92ZI-]'LZX\M5MN:D]8V M!31[JP3:S%M$1:[@(EL*ZZX*`\;"0L16X:(KM?C64-`P$8PA82'C6R3..BHB M+:I,8V-CVB!2(M63%F@1)),@`4B9`*```:/I5K`0-$-(I]\II'*F_=-0/T4S' M.0$V_P`+EJ4^#*_W0WG@]`_TW?J_^U/'7L_J/W7`;,#@#@%2956:R"I1[H&`>`7GSWV370S,V<^4]$.8 M-1&WSF)DLL]KL_B"_3UJJ$/(*#UI5T8:QS;3(#!,JX`()QUKCT4R]PJ8```` M8/88X[5MMQ+E)2LC8)W<,)1)Q.2#OKUK"YG)#IE$W)U M-V-_'1J!A*4>0&5`1_)P"\^JOM4FV!@:34HV$)_(&MS+;ER$9"4O3=5G6!\KWIZ=(\=CPA`,(=%QZ!P#,-([+ZX MS])QE^W<=Q'51KQN;9QX12H,?=YZCX@@'2@EZYA%)3#^RV(&()B=,#Q`5@.@ M<>2).`N0^QHVU_JR0OT5/F3^7.4OHT_)YY;^N?K?QW[KX"SW@#@-9YJ]VD=S M3$NI>\:@=RO2EJ&WB\"C8)F5@WVG[5U>COJQ7%)1T[11-3BT>R99B6#"#42( M=A'0L9&MNJ,0C[HVAF1)0(.9C]0N+VM:LZL MHF)6CN/E]1[ES<3J-T3^EYV6;B51YCS0*/,.`;FJENJ=\K\7;:/9Z]1S]LH'H*)*'*/Y!X#T/`'`'`'`'`0JU7[-$7V$,0@]SO612`>0< MP$`Y<`O?;^S'Y(TO6*1R=LZ[DNH71=9#+J2(8FR#/R5[PY,+^N%CY)U%=YKF MAR'(7F$["VPX@'INEP$6;-VAO<5VI[E"XDW2\?:/=7D4J_4BC93T;ZA,;,\O M-P;D'KG]LQ&T>G5(MR1,)"NZ[3FQS&`G7";ES"YG\19H>^`^HK[OO[1OR*I' MQ._!#XR/C*]S^*_=W`7Y<`<`NMJU[4AM(Z674U7(K+MJU)9`A5WT>YINGNFO M;&W1EF2ZK11B[O=I6J&/?2NDA(')RY]`?0$*W#;V^_%N"%!CMB[3LAA M['TZJ1M$9[U(I/WS$62Q`$)V(FKP;$F+"F1(<%#))!9BE[A0*H(\A#OX_85W MB==)49/=;W?;W$U&2Z;B6P'I?4>(5]1%R;T\8^-'L,88N8N4$!$G3"MSQ/0` M%#AS$0M1TJ]FSVA-*0QDG&:8(O.-UC5$7`7G4I*N?`7&>9#"WR0XO\BO-KY`53XNO@#XI\BOU5[1]BX#*'`'` M5OZ:=H[;:T?R;JVX3TD8@@KPO)2$^]RA;H3SCY*"3D'J\I(2#?(&1G%FLD(1 M1TN8_5,7+5LF7D4B92E``#WN3=S;;IPQ,+5W*FN?2=1+`U5,@\@;%GS&3*:8 MKD/U9T7\4:R&?,52G[@E63((1TI% M2;9)['2+!V@8Z#ID]:+D524(82'(8#`(@/`=CP!P!P'T44313.JJU!ZK<\8MP5GFQZ3-H/31>%L M:3]NJW?8SNH>R,%1*Z6481K^)-=Y&R,TO"+6/D'9(*N0SADLX;N)!<"KAA_> MK[.AMU;<&U-F+4'A=AF6U9TH4YAV,B8@\EI.^BSII_X`8;_`*.JYP%>^_C7/#YAC;;BRVS5+L3V`QN];V*]UAS,UYVPE_!,_1&\DDHDBLF)EP2 M,(B!1*8%5OQ,>7_A*?[CS_'#]/CY2?\`U/8>`V&'`86U),;')Z=<^1M.Z_WW M2&%LIL:KWL)@<^^-W1IU"#[W$OI@7\)J)=#EW>ERX!?_`+(\6J$V9L:)5\C- M.=1SAGU/(B;#OU:QGM7[@]LMCE)M#DTCYRKI!6.F0',W>*%,T>K1R8J_O8N9:SV)FU M1`?5*K%#T1X#3V>9#+7P8F/H<^>_UIQ\4OPG]#Q/^Z];X#>9<`<`DMEOYTG9 MF=:.<]06*<(VG4/LX:OKRKD_)E+H"1W5CTKY-E3B,T_8"J!FE;:-U%CI1RD@ M9"$FHCO2.7>-7S%!<0X6^IO.[;VX3LKYZJ^FO4G5IK*-CL."I!KA2WM9*BY> M1\%9CI4M--R4ZQM6BLT:$CFBJSE>*6D&1$DS'!=VK-/&FC#2V M3]>6FYJ^@,*XV1DJY3\C0^3;BB]84>$2=QH4[&JELLQI-!P04CH=Z@HFJ`E. M!1`>0+:ZM-9^HWM16;JEH"T!4#(6+MN&FWRO6C5)J;NM?-%'LJ-?>ED&*DBB M"CF-BVC!(.^JU53.%9::E^]WSY-HV9F%J#:7V4.AOY'(WZ"WVH).F;UFY2,BY:NVRY%$ M'#9PB5^ M72YA47.,885QMV6?94QS.MK`?2]-W]RS M5*LV89)S)EBRP0*$$!+WS`HVR,B9)(#%YBFZ173-Z!BB'`_1*Y]L_4.4A\2Z,D"CSYJJR6!!(7D`CZ8$?2-RCKA(*]$G+N^EY]WN<^[R"IK/ MF_-OZ8,SI5M,$/ES0OJ2U$VB6\`!B'27CH^?K)!6#K#HA6YM_4FHUD;,55,P M+1S)\]>,P(<72:`%X!AGSN=HP^1+&GW6GG+\4XJ^\2^3'R^];]P^*?=G`,Q\ M`<`(`=)2"KIHRIMCB9M)OE3D*L<&D=LS9PT3[5]'3 MB=/U!).95E8M%C?=0M^183>7+J<2)B\:DF2M4F]0JRS@@&)#1";1ER*0RX.% MRBN8+5N`.`X$I*1D'&R$S-2+"'AXEDYDI66E';>/C8R/9(G`4,W$NTT/I7*1]$.RYBYUK3U56)VM7`RU7H![<\5 M5*0'DV>KT"'C@(7)[V#.KUB\TY6:U".Z`+*+R*`*D('1Z!>S,6C)N44=<>^' MEF8U>:F[([:V`^#I.RJ63&E:41-WU%Q.29Y$$6UW2@SJ=!&M0I&-/8%*+<"R M+0P$*#A4)!PM9AHJNUN(BZ_7X*/9Q$)!0D>TBH:'BH]NFU81D5&,$D&4?'L6 MJ14T442$323*!2E```.`[3@#@*TMR+=DT<;7..26_4=?.^+U/L5U\:X(I(LI MW,>3G1%#-4@KU7,\;!'0(/2BDO,2*K2+0.`I]<=<4T%`5UMV(=YCM%)9-\LAD_+5=1<)+MGTW6'ZU8LN0G3EN0%$WUA)!U9L/5N& M$<\43.<.@?#BG^)_?#Y30OB#].>W?$_NGUG]UP&L MR[83X.^UQQMWWX.ZSYH.%N7/WT^&NCYT\V^N?/J>?I^MY<^YRX! M9S(_@3PN[\M/7EOC'\X/A?U`^V_9O\/\W`8F4\"=`WDUZ'_F><'H?][\W`<+ M_,G^QO\`S!X`_P`R?[&_\P>`/\R?[&_\P>`:(_R']2__`,L_^T7K?_U__=X# "_]D_ ` end GRAPHIC 4 g393105g78y27.jpg GRAPHIC begin 644 g393105g78y27.jpg M_]C_X0`817AI9@``24DJ``@``````````````/_L`!%$=6-K>0`!``0```!D M``#_X004:'1T<#HO+VYS+F%D;V)E+F-O;2]X87`O,2XP+P`\/WAP86-K970@ M8F5G:6X](N^[OR(@:60](EG)E4WI.5&-Z:V,Y9"(_/B`\ M>#IX;7!M971A('AM;&YS.G@](F%D;V)E.FYS.FUE=&$O(B!X.GAM<'1K/2)! M9&]B92!835`@0V]R92`U+C`M8S`V,"`V,2XQ,S0W-S7!E+U)E&UL M;G,Z>&UP/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C`O(B!X;6QN&UP34TZ1&5R:79E9$9R;VT@&UP;65T83X@/#]X<&%C M:V5T(&5N9#TB"\T8C0'6'?K_^X` M#D%D;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$! M`0$!`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$" M`0$"`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,# M`P,#`P,#`P,#`P,#_\``$0@`,@"B`P$1``(1`0,1`?_$`(\```("`P$``P$` M```````````*!PD&"`L$`0(%`P$!`````````````````````!````8"`@`# M`P8$#A,``````@,$!08'`0@`"1$2"B$3%#%!%38W.",S%AAA8F,T5#6U=K9W M&3E9&H'!(C)")&15996EUA=79UC8*EH1`0````````````````````#_V@`, M`P$``A$#$0`_`%S;PW>[DD_;1(94[V!L(P;RLU]JXC%*@95LH"W-RK\IC$4? MJB+UJ2;A@>*N<6[W:1(IK7+<3M\+],ELY/(W*+OUS=9GY0+[88M57)E3XMQ3#96<6=)U4+C$R&WM87LHPX;6BC1V$WAG>QFQ-8R&7698FGS;4RR6R17.'=]DL8@UX*)9%4T1+BKR^'K`M M4BE\=4/(UZ!,8$*U.D"I.!D2:+Q\ MI9)(!&&F"\,9SX``'.<^&/FX%,^?4.]+@Z6_P"D`J#_`%38_P#N/P-W-1M_M.M\6Z<.VHE\1*\F MZMEK$W3E5%4TA2@CBV3$.:IB(6AD#*S&#$Y$,RH1>2L&!_`B\(;A\`X M!P#@'`.`<`X!P,:,A<..E">;G1.-&S1(A&V))>8Q-8Y0E;3<#":WIW\27+J2 MA,"8+`B@FX+S@6?''MX"#?J'_4(;@ZM]A;GJ5KE$JAC,1UK!7K\[2&TZ@B=I MOM@S"80Z/STY0W&3=`Y$1.*(6Q_2HB3&<"-U-4$'F_'!"(HLH,Z[4O4E[+L' M6QURV+3%1US`[.WRK.PI[9[U/H.VV7#8F&GYL57+TS5_#9VF=XVZ%2N7I371 M.:\D.7P#1E*#R&G'X4EA=!Z;7M)MGM'TSG[A?T)A[18M`6"DJAVD,$C2>+06 M?QMTBZ)]85I432ARR,#ZWI3C4CDB0A`WY+PG.*)("?DD`,&QB(1.$MF66&1> M.Q%FRJ/6Y:8PRMK`V96JLA$J5Y0-29(E^*4B#C)AGD\X\XQXYSP,BX!P#@>1 M>C+<$*Q`<(825R10C-$7G&#`EJ21DC$#.<"Q@>`CSX>.,X\>`F9"U M5;%B-=S;@J7B'5[/)FVIETYJHUO.. M,#QG/CP%I_3C=-VM';O)-LF;8V:7%#T]%,=.N<2'4CY$V0U>=8#A8Z5Y"^CE M,.EX5!:8N()OA\$A(R'(S/-D7B'&`N?W!E+EZ2V<4_3G7>6EMV.;Y'K95;*S M;$LR:.\?<*>=V.+1HF"**P-J9(VI%R"RUPEF%I#@,9I1.2Q%A"((P?T+%D99 M8\^'B(`19\/D\1!QG/A\OL]O`^_`.`<`X!P#@'`.`$94JC==.CA"4ZM7:[FECST2N]PY@3I6\ ME:6G*4YR,\L@&-XWJMU9]S?73JPO5:\1R0:JFP5K>-?XLE3KZUE-))VPK,1> M(?''2!NS:Y118P+X\8TNB1&L-;UAJ#`A_$!`29P+`]3-/-;=&J=::&U8JI@J M2L6E:J=LLC,-P7+7A_<"DQ+C))-('I8Y2"32)P*1D@-6+E)YWNB2R@Y"446` M(;+\`X"=6POK#M7*-W?DNMR'72>SRAZXL-SK"Q]B6N8-Z%W)>X^]&Q^52&$5 M:='E`I1$F!T2GX+,.>4*MR)*R:24'`BPF`X&S/#7(6=J?V1<0YLKXVH7AH)7!K<.Z=M1B<26/IK#@=/R3:^R*\M M%\85Z3+NSX;J_8$J.HX6>]H3BS$C.X*VSR`-"6H*3"_N,!>/Z:WNKO7>%PN' M1;>?WHMP=<6I8]():Z,J:+R>P(9&9"FA$W9[`CZ9.@1H[+K25+4:=::2G($X M)UF!FDA4)5)R@*P=Y>Y[M3[1-^)]H!TH'OS@,$[C]CUJ=*/3E0,[VE5)KJWJ55[`Z8;&Q^E2R5H;!V$S%SEL MKE\ME9`DKJ^1&,I6U2XN*HK)1R\S!"0)I)BL!P`6FH6N_5I=DD29-P(QLO/Z M>JBR5)$FAB%?223/\`A7-),UQ)EPC9@)D8U0,O#N3@W.#,9+*R(?AG`<\"H_\`EE.U M[^D.VS^QCZ?^V"3?MI^R_P!<_C_U3\;^FX'9-X"%?J0M&>FB2;V16V=F>PF4 M:?[#W#'X:=:]=0RE'K80M\C;$C(B,;L1Z;HJI;UM4+5["S%(O?KC%I2\I`$\ ME#G(#S#08S9-J^KCI7ZXM64BJ_FEJU7)A30R:_21O-669,+P+>P#F+K+HZV0 M=K5JY,I?EDA->'18F2)VU"-=@(\IPC)*R%@NHNX^MV]E*L>P.K%GL]J5>^JE M;7AW;D[BUN3(_MP"!ND9E,<>T;<_QB2-H%10S4:U,2;[HTLX&!DFE&##9S@' M`3TV`]'=J3>&Y\KV-2;&6=`Z8L>Q76S;`UZ:(FS+EQKQ(WLR0RA@A=IJ7LD^ M+15Y'`]WK4BBC]DNL4DXL!Q)T?N4HTHT.!EFE&3RH`&%F`%C(1@&' M.<9QGV9QG@=!5,6`I,G**``LLL@HLLLL.``+``L(0```.,!"`(<>&,8]F,<# MGK=:+?@_U=G80T(C1-0'5UW<2C.0XP2(HUR=6@XU6$`/($9_QIGQ& M;/M]O`6_UBTNI>/;]WAI3V#;?SOKY?(3)99`RK;!#C'^'KYS&)$(LEMG[@=* MX@*-Q:8,W@Y-#Z:,UL.",H1@RRE!1W`OCST1]60@Y_\`9,Q^>T>X6!'W^O9M(5!."H\VNX9-\: MT.*D1+88(DW`S@B4)O.%UOJ8M_\`1F^^G_8&M*1W!UJMNQ'B:4.K:(-7-T5_ M,9:Z)FBYX6Z.I[>P,#\O!S?/\`Q_X'=XX' M/Q]1#Z?K;/9SL+=-M:%L2CG2(;+@K^/J8Y<5S1>IG^#S&&PR.0(]`T%S52A3 M2^,KF]C3+22F<:MT*/4'%919"$HPX,[[5/3=;(O'6QUS5[55W57++#T+K2Q( M%:2&RYXBJ^"R?%PSHBPW1X@$VG1C9'6LF+2I28U)RGDUMRO:0)18&4<1A,8% MTOIK.K6VNL73B=M=WSN%RJPMA[%06F?'ZUDAA+K)TAT0I9_ MVQU#N^Z[$K;=6KZ6F'Q5_+:Z;U<;CS8B?I'%BE".'QYA(87]2380@+TRE0IR M48$L`?#.,Y$$Q]J73/JGVSRB@+;NZ\[,KPC7E-*&V*JZLD-=IHZ]9E+]&75< M%^72N+R8`STZV*E$E83'$>&#!X%C(O+D(6%%;K:_!V?=]1CY7E#9K%1$3V%/ M=W`38CKY7`9E8<@JUB3-TQ.=`I%LI42R,*BQ(`E^;W6`B"(6^3G(O*A+.< MSAB\V<"]YG&.!D79YT>==G9DK26-LI%G2N[;:&Q*P)[]J^2M4!G2IH38$6UL MTK4O#8]129(D&1>1)]*(%*I*5^"3G%%YR'(+NV/Z4GJ MW@KAQ3YK-BEG.-'AH^!I;'FIDB?2ZL`6RE"C2L`D(O(;A6=GR8\OR\"Z+;WT M]NGNY>M6CVF4\OV[8TQ:%U\[PBMU<0?*R+GDK97IBA3*>YSE&\0EV1FJ2TL( M2F`&A1HBO,<9XAR'(M0LB%.U$ M*C`&F)0FFF`38\XBP8!Y\Y\,8^3@4);E=1_5[W3/]OVU:5;7%1=R4;;22).0I"23@O`5KB] M&;UD`;RW86X^TH6HU2)&4YBF-"8;S58`B&-*6LS5GPPU(0!SG(,"R+&,9SX< M#)?ZHAUE_P#>;L=]2?R.^O-#?M9^SOLV_7'Z/XK]+P'*N!RZO5@:Y[W2WM0= MID^5W<-F47+H16[#JTOB45E,OAS:U)HJSIIC!6,IB1N2-LF)EEAVRYH[=D.J;;ZJ.NZ?I=E&.?P MZNI)=*Q^ULA=DH75I?&R$G1QK!+7MC9'P)3HR0>32W`SD!(BB"3U12M82`0% M6#30:YX!P#@'`.!`VTM+,^QNMM[T,^M#4^MENU-/8`8TO@U);.K4R6-N+:W! MS'J=UP0A9I/L)6VMU"-MP5[N[1&- M3K$VB):.TWNZCE=3[EN^PCP]9N.T]'PVS,; M-^@9I5QX6ID=E3R\(B5(#E@"DV%H,`#:"B^L/1G=#L%B3H^]>%F0O0R(=6;& MP496%]U3:M0-4"M1[W!OS$\:W!F>W)*Z-MD?13NH=D2=2N,6)$#P!Q(`7DY. M<`,!Z_\`1ZQMV+!U%I3M#HB[[:UXUTZ[+N20>+;#,]ELL/:KH_/NM:H8@XR9 M6I&Q8?+81ZH1:/EM)BTT:XAD&4X$!P(T"C@:^0ZAK0#!-%';M*TYW?W7T:J* MH-M:+B=,1&"6S8\WIZZ(5N%8C-2UE733S`ZQV>3UBD.J;8R,D8?U)2Q(C3D! M,\G^,!/R$U:WZ_[54)--*]M(MJCM)$].*@WVW5:M<=:I&R.]B;%ZJZK;1Y#59MU.D)=2Q2KF3K MDWZ:>_\`0W@Q.+_V)+VFSC*G#9Z6YR7:4[%..U1LL!5$@H]UK4)Q86,*')1R M$X#>%+DP/Q60P7M>IJ"5U4O:G(-^=)]HK0WLD]W3B5:O;^XK^P[#UI8=?GZ= MQ4&OS+&[&9)%FO:.:8%$#QLJEC7I,J"7(W\(8H&<$)099MAI[N?*UD^?I%35 MX272XGMR[`[#N"L6K6NQ]B?RG%-X%0Q&N]YN6M<5LREI;>52%F-3RD;E[<[F M(&A=D:G)2CSX+X'FO+4BB95K5IFA24EN$R+ZT6[)KT-6LG25?THUN>SYK-XP M!P?I]K$JV$6S:K[$&ECB1.D?RI6H-=FP`AEIB@8\O`TX_P"`VW?_`,WU$?8Q M](?=9V?^IO\`SQ^\7];O^CWUE_RC@=-K@'`.`<`X!P#@'`.`<`X!P#@'`.`< M`X',3V+_`)\"U/J3_.2NWWOONE_;:+ZZ_J'^:/\`2/P_`Z=F/DQ_:^3^QP#@ $'`__V3\_ ` end